We are the association of generic and biosimilar companies in Germany. Pro Generika represents the interests of its members who develop, manufacture and market generics and biosimilars. Through the use of generics and biosimilars
important financial resources are saved in the health system - while maintaining the same high quality of pharmaceutical care. Generics and biosimilars thus ensure sustainable access to modern medicines for patients.
We are committed!
For the industry
For the patients
For the policy makers
Pro Generika has 17 member companies in Germany. Together, generics and biosimilar companies cover 78 per cent of the total pharmaceutical demand of the statutory health insurance funds.